1. Immunocytochemical analysis of uterine papillary serous carcinomas for estrogen and progesterone receptors;Umpierre, S.A.; Burke, T.W.; Tornos, C.; Ordonez, N.; Levenback, C.; Morris, M.;Intl Gynecol Pathol,1994
2. Progesterone receptor levels independently predict survival in endometrial adenocarcinoma;Nyholm, H.C.; Christensen, I.J.; Nielsen, A.L.;Gynecol Oncol,1995
3. Estrogen and progesterone receptors in endometrial carcinoma: comparison of immunohistochemical and biochemical analysis;Nyholm, H.C.J.; Nielsen, A.L.; Lyndrup, J.; Dreisler, A.; Thorpe, S.M.,1993
4. Aggressive endometrial stromal sarcoma responding to medroxyprogesterone following failure of tamoxifen and combination chemotherapy. Case report;O'Brien, A.A.; O'Briain, D.S.; Daly, P.A.;BrJt Obstet Gynaecol,1985
5. Widholm 0. Sarcomas of the uterus: a clinicopathologic study of 119 patients;Kahanpaa, K.V.; Wahlstrom, T.; Grohn, P.; Heinonen, E.; Nieminen, U.;Obstet Gynecol,1986